Li-Ming Zhao

Title: Innovations of Li-Ming Zhao

Li-Ming Zhao is an accomplished inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of breast cancer. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Li-Ming Zhao holds a patent for "Triphenylethylene compounds and uses thereof." This patent describes triphenylethylene compounds of formula (II) that serve as dual aromatase inhibitors and selective estrogen receptor modulators. The patent outlines methods for treating patients with breast cancer, including those who also suffer from osteoporosis, using these compounds or their pharmaceutical formulations.

Career Highlights

Li-Ming Zhao is associated with the Purdue Research Foundation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Li-Ming Zhao has collaborated with notable colleagues, including Mark Stanley Cushman and Wei Lv. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Li-Ming Zhao's contributions to the field of pharmaceuticals, particularly through his patented triphenylethylene compounds, highlight his role as an innovative inventor. His work not only addresses significant health challenges but also exemplifies the importance of collaboration in advancing scientific research.